Botanix kills superbug Staph for Surgical Site Infections

Antibiotic resistance could cost the world $100 trillion by 2050, and approximately kills 700,000 per year. Some in the scientific community say it could be as bad as cancer. Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. The World Health Organisation published a list of bacteria...

Categories Research

CXi Software: a funds system of record

Fund managers all need a unit registry. A record of their transactions, to do reporting and income distributions to investors. There is no dominant system for this, hence it’s done with a combination of software, manual spreadsheets and black-box solutions. At CXi Software (CXi) we want to streamline and automate this work. Bain Capital Ventures...

Categories Research

Clean TeQ Overview

Clean TeQ (ASX:CLQ/TSX:CLQ) is a world leader in metals recovery and water treatment technology. They have proprietary technology developed over 20 years. Peter Voight founded the company in 1990. They are developing a world class supply of materials for lithium-ion batteries and light-weighting aluminium. Mining legend billionaire Robert Friedland They started applying the technology in...

Categories Research

The first innovation in the Acne market in more than 20 years

Matthew Callahan is a serially successful entrepreneur. In particular, he has a proven track record in the life science industry and is responsible for more than 4 Food Delivery Association (FDA) product approvals. Matt Co-founded Botanix Pharmaceuticals (ASX:BOT), his latest biotechnology business in the dermatology industry. Botanix uses a proprietary technology called Permetrex™ to enhance...

Categories Research

About Me

My name is Mark.
I’m an Early Stage Technology Investor and help with marketing.
Founding Investor and did Marketing at CXi Software.
I’m part of an investor community called IO Private.
Mentor at Startupbootcamp Australia.